Literature DB >> 30639539

Optimal age for screening colonoscopy: a modeling study.

Chen Chen1, Christian Stock2, Michael Hoffmeister2, Hermann Brenner3.   

Abstract

BACKGROUND AND AIMS: Recent guidelines on colorectal cancer (CRC) screening recommend starting screening earlier than before. We performed a simulation study to examine and compare the optimal ages to have once-only screening colonoscopy and repeated colonoscopies.
METHODS: A Markov model was set up using data from the German national screening colonoscopy registry to simulate the natural history of the adenoma-carcinoma process. CRC deaths and years of potential life lost (YPLL) for a hypothetical unscreened 50-year-old German population were estimated for a single screening colonoscopy or 2 or 3 screening colonoscopies with 10-year intervals at various ages.
RESULTS: One single screening colonoscopy performed between 50 and 65 years of age was expected to reduce CRC death by 49% to 69% and YPLL by 51% to 68%. An inverted U-shaped association was found between screening age and proportion of CRC deaths or YPLL prevented. The optimal age for once-only colonoscopy that yielded the highest reductions in YPLL was around 54 years for men and 56 years for women. Estimates were approximately 6 to 8 years higher when proportions of CRC deaths prevented were examined. For 2 or 3 screening colonoscopies, the optimal starting age fell to around 50 years or even younger for both genders.
CONCLUSIONS: Based on the YPLL estimates, in a high CRC incidence and high life expectancy country like Germany, the optimal age for once-only screening colonoscopy is around 55 years and possibly slightly younger for men than for women. When 2 or more screening colonoscopies are offered with 10-year intervals, screening should start at age 50 at the latest or possibly even younger for both genders.
Copyright © 2019 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30639539     DOI: 10.1016/j.gie.2018.12.021

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  7 in total

Review 1.  Worrisome Trends in Young-Onset Colorectal Cancer: Now Is the Time for Action.

Authors:  Gaurav Patel; Prakash Patil
Journal:  Indian J Surg Oncol       Date:  2022-01-16

2.  Designing optimal allocations for cancer screening using queuing network models.

Authors:  Justin Dean; Evan Goldberg; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2022-05-27       Impact factor: 4.779

3.  Gastrointestinal Biopsy Obtained During Cancer Screening, a Biological Marker for α-Synucleinopathy?

Authors:  Jelena Jotanovic; Jelena Milin-Lazovic; Irina Alafuzoff
Journal:  J Neuropathol Exp Neurol       Date:  2022-04-27       Impact factor: 3.685

4.  Microsimulation Model for Prevention and Intervention of Coloretal Cancer in China (MIMIC-CRC): Development, Calibration, Validation, and Application.

Authors:  Bin Lu; Le Wang; Ming Lu; Yuhan Zhang; Jie Cai; Chenyu Luo; Hongda Chen; Min Dai
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

5.  Evolution of colorectal cancer screening research in the past 25 years: text-mining analysis of publication trends and topics.

Authors:  Shelly Soffer; Eyal Klang; Noam Tau; Roni Zemet; Shomron Ben-Horin; Yiftach Barash; Uri Kopylov
Journal:  Therap Adv Gastroenterol       Date:  2020-07-20       Impact factor: 4.409

6.  Germline mutational profile of Chinese patients under 70 years old with colorectal cancer.

Authors:  Teng-Jia Jiang; Fang Wang; Ying-Nan Wang; Jia-Jia Hu; Pei-Rong Ding; Jun-Zhong Lin; Zhi-Zhong Pan; Gong Chen; Jian-Yong Shao; Rui-Hua Xu; Qi Zhao; Feng Wang
Journal:  Cancer Commun (Lond)       Date:  2020-09-10

7.  Strongly Divergent Impact of Adherence Patterns on Efficacy of Colorectal Cancer Screening: The Need to Refine Adherence Statistics.

Authors:  Thomas Heisser; Rafael Cardoso; Feng Guo; Tobias Moellers; Michael Hoffmeister; Hermann Brenner
Journal:  Clin Transl Gastroenterol       Date:  2021-09-10       Impact factor: 4.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.